Subacute cutaneous lupus erythematosus induced by nivolumab

Australas J Dermatol. 2018 May;59(2):e152-e154. doi: 10.1111/ajd.12681. Epub 2017 Jul 20.

Authors

Rose C Liu¹, Deshan F Sebaratnam¹, Louise Jackett², Steven Kao³, Patricia M Lowe^{1

4}

Affiliations

¹ Department of Dermatology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
² Department of Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
³ Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
⁴ Central Clinical School, the University of Sydney Medical School, Sydney, Australia.

PMID: 28726325
DOI: 10.1111/ajd.12681

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological
Biopsy, Needle
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / pathology
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Immunohistochemistry
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Lupus Erythematosus, Cutaneous / chemically induced*
Lupus Erythematosus, Cutaneous / drug therapy
Lupus Erythematosus, Cutaneous / pathology*
Middle Aged
Neoplasm Invasiveness / pathology
Neoplasm Staging
Nivolumab / adverse effects*
Nivolumab / therapeutic use
Risk Assessment

Substances

Antineoplastic Agents, Immunological
Nivolumab